Medicine and Dentistry
Rheumatic Disease
100%
COVID-19
87%
Disease
38%
Musculoskeletal Disease
37%
Disease Exacerbation
28%
COVID-19 Vaccination
27%
Disease Activity
24%
Severe Acute Respiratory Syndrome
23%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Rheumatoid Arthritis
20%
Inflammatory Arthritis
20%
Drug Therapy
19%
TNF Inhibitor
17%
Disease Modifying Antirheumatic Drug
15%
COVID-19 Vaccine
14%
Inflammatory Disorder
13%
Infection
13%
Vaccine
13%
Systemic Lupus Erythematosus
13%
Adverse Event
12%
Rare Disease
12%
Antirheumatic Agent
12%
Ankylosing Spondylitis
11%
Polymyalgia Rheumatica
11%
Juvenile Idiopathic Arthritis
11%
Systemic Scleroderma
11%
Monotherapy
11%
Observational Study
10%
Connective Tissue Disease
10%
Body Mass Index
10%
Retrospective Cohort Study
10%
Coronavirinae
10%
Hypocomplementemia
10%
Hemophagocytic Lymphohistiocytosis Syndrome
10%
Adolescence
10%
Hemophagocytic Syndrome
10%
Immunity
10%
Comorbidity
9%
Rituximab
8%
Odds Ratio
8%
Methotrexate
7%
Janus Kinase Inhibitor
6%
Diagnosis
6%
Pulmonary Hypertension
6%
Logistic Regression Analysis
6%
Side Effect
6%
Vasculitis
5%
Lupus Erythematosus
5%
Prevalence
5%
Glucocorticoid
5%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatic Disease
75%
Disease
29%
Disease Modifying Antirheumatic Drug
23%
Severe Acute Respiratory Syndrome
23%
Systemic Sclerosis
22%
Comorbidity
22%
Pandemic
21%
SARS Coronavirus
21%
Rheumatoid Arthritis
18%
Inflammatory Arthritis
18%
Tumor Necrosis Factor Inhibitor
16%
Ankylosing Spondylitis
15%
Disease Activity
14%
Non-Steroidal Anti-Inflammatory Drug
14%
Monotherapy
14%
Infection
14%
COVID-19 Vaccine
13%
Vaccine
13%
Adverse Event
12%
Juvenile Rheumatoid Arthritis
12%
Glucocorticoid
12%
Prevalence
12%
Hypocomplementemia
10%
Spondylarthritis
10%
Inflammatory Disease
10%
Coronavirinae
10%
Musculoskeletal Disease
10%
Methotrexate
9%
Side Effect
8%
Psoriatic Arthritis
7%
Disease Exacerbation
6%
Chronic Respiratory Tract Disease
6%
Pulmonary Hypertension
6%
Cardiovascular Disease
5%
Immunology and Microbiology
Systemic Scleroderma
33%
Rheumatic Disease
32%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Prevalence
23%
Severe Acute Respiratory Syndrome
23%
Ankylosing Spondylitis
11%
Juvenile Idiopathic Arthritis
11%
Adolescence
10%
Vaccine Efficacy
10%
Breakthrough Infection
10%
Hemophagocytic Lymphohistiocytosis
10%
COVID-19
10%
Body Mass
10%
Centromere
10%
Glucocorticoid
8%
Antinuclear Antibody
8%
Autoimmune Rheumatic Disease
7%
Comorbidity
5%
Inflammatory Arthritis
5%
